NU 665B WEEK 5 DISCUSSION
NU 665B WEEK 5 DISCUSSION
Complete this assignment according to the Week 5 Pair Presentation assignment instructions.
Please refer to the Grading Rubric for details on how this activity will be graded. Please remember that you and your partner must each submit the assignment, even if it is the same file so that you both receive feedback and credit.
You may view each other’s submission and comment if you would like. Reply posts are optional for this assignment and students will only be graded on the Pair Presentation that they submit.
Primary Care of the Psychiatric Mental Health Client II
Week 5 Presentation Instructions
You and your partner will create a 15–30-slide PowerPoint presentation with voice over on one of the following topics:
ADHD
Social communication disorder
Oppositional defiant disorder
Gender dysphoria
Depression
Obsessive compulsive disorder
Social anxiety disorder
Reactive attachment Disorder
Autism spectrum disorder
Self-injurious behavior
Traumatic loss / grief
Bipolar disorder
Generalized anxiety disorder
Separation anxiety disorder
Movement disorder
Eating/feeding disorder
Completing this presentation will prepare you to:
Remember the diagnostic criteria of your chosen topic.
Create an evidence-based treatment plan for a patient with the chosen condition, including pharmacologic and non-pharmacologic treatment
options.
Summarize factors that may lead to positive and negative outcomes for patients served and how the role of the PMHNP can improve outcomes.
Create your PowerPoint presentation with the objective of teaching your peers about your chosen topic. For tips on effective preparation of PowerPoint
presentations, see standards of professional development for Microsoft PowerPoint presentations.
The assignment must include the following:
- Three learning objectives for the activity
- DSM-5 criteria
- Screening tools with validity and reliability
- Pharmacologic and non-pharmacologic treatment options
- Differences in symptoms and treatments across the lifespan, if applicable
- Ethical and legal considerations
- Potential barriers to treatment related to cultural and/or socioeconomic factors and how these impact outcomes of populations served
- An analysis of how the PMHNP role can serve to improve outcomes for individuals with your chosen diagnosis.
Introduction
Psychiatric disorders in children, adolescents, and adults present complex challenges that require evidence-based and individualized approaches to diagnosis and treatment. This presentation aims to provide a comprehensive overview of a selected psychiatric condition by integrating current research, diagnostic standards, and treatment strategies. The goal is to enhance understanding of the disorder’s presentation across the lifespan, explore appropriate management options, and highlight the critical role of the Psychiatric-Mental Health Nurse Practitioner (PMHNP) in improving patient outcomes.
The selected topic will be examined through a clinical and theoretical lens, beginning with a review of the DSM-5 diagnostic criteria to establish a foundation for accurate identification and assessment. Validated screening tools will be discussed, emphasizing their reliability and clinical utility. The presentation will also outline pharmacologic and non-pharmacologic interventions, supported by the latest evidence-based guidelines. Additionally, it will explore ethical and legal considerations, along with cultural and socioeconomic factors that may influence diagnosis, treatment adherence, and overall outcomes.
By addressing variations in symptom expression and treatment response across developmental stages, this presentation underscores the importance of lifespan-informed care. Furthermore, it examines potential barriers to effective management and provides strategies to mitigate them through patient education, collaboration, and culturally competent practice. Ultimately, this presentation seeks to strengthen clinical competence and reinforce the PMHNP’s pivotal role in promoting recovery, resilience, and quality of life among individuals with psychiatric disorders.
Leave a Reply
Want to join the discussion?Feel free to contribute!